 |
市場調査レポート
商品コード
1355807
皮膚科学- スキンケアとエステのセルフケア市場の現状と将来動向Dermatologicals - Exploring the Current & Future Self-Care Market for Skin Care and Aesthetics |
||||||
| 皮膚科学- スキンケアとエステのセルフケア市場の現状と将来動向 |
|
出版日: 2024年02月29日
発行: Nicholas Hall Group of Companies
ページ情報: 英文 442 Pages
納期: 即納可能
 |
- 全表示
- 概要
- 目次
パンデミックによって、衛生とパーソナルケアが世界中の消費者にとってかつてない関心事となりました。パンデミック後の防腐剤・消毒剤の安定化により、全体的な売上はある程度抑えられていますが、市場力学の多くは絶好調で、活力と将来の成長機会に満ちた市場となっています。リップケア、ニキビ治療薬、創傷治療薬などが好調なのは、旺盛な需要を示すいくつかの兆候にすぎません。eコマーススキンケア市場の売上は30億米ドル近くに達し、前年比でも高い成長を遂げています。
発売活動は、成長を促進する鍵であることに変わりはなく、配送形式や処方の革新が頻繁に行われる一方、手術後の回復のようなニッチな分野では、新たな視聴者を獲得できる可能性があります。A+P投資は、いくつかの分野で重要な促進要因であることが証明されています。マーケティング担当者は、消費者を教育し、製品を促進するためにデジタルチャネルに目を向けています。パーソナライゼーションも重要な動向であり、消費者は「画一的な」スキンケアソリューション以上のものを求めています。
当レポートでは、主要8ヶ国（およびその他の主要市場）の皮膚科学市場を詳細に調査し、主要国の規制と分類、様々な皮膚疾患治療薬の動向、主要ブランドのパフォーマンスと発売活動を分析しています。
目次
エグゼクティブサマリー
ブラジル
- 概要
- 流通
- 規制と分類
- 抗真菌薬
- 創傷治癒薬
- 防腐剤および消毒剤
- かゆみ止め
- ニキビ治療薬
- フェミニンインティメートケア
- リップケア
- 痔処方薬
- 循環補助器具
- 脱毛治療
- 湿疹と乾癬
- 頭皮トリートメント
- シラミ治療
- 髪と美容のサプリメント
- 見通し、予測、機会
中国
- 概要
- 流通
- 規制と分類
- 抗真菌薬
- 創傷治癒薬
- 防腐剤および消毒剤
- かゆみ止め
- ニキビ治療薬
- フェミニンインティメートケア
- リップケア
- 痔処方薬
- 脱毛治療
- 頭皮トリートメント
- 口唇ヘルペスの治療
- イボと疣贅の治療
- 髪と美容のサプリメント
- 見通し、予測、機会
フランス
- 概要
- 流通
- 規制と分類
- 抗真菌薬
- 創傷治癒薬
- 防腐剤および消毒剤
- かゆみ止め
- ニキビ治療薬
- フェミニンインティメートケア
- リップケア
- 痔処方薬
- 循環補助器具
- 脱毛治療
- 湿疹と乾癬
- 頭皮トリートメント
- 口唇ヘルペスの治療
- シラミ治療
- イボと疣贅の治療
- 髪と美容のサプリメント
- 見通し、予測、機会
ドイツ
- 概要
- 流通
- 規制と分類
- 抗真菌薬
- 創傷治癒薬
- 防腐剤および消毒剤
- かゆみ止め
- ニキビ治療薬
- フェミニンインティメートケア
- リップケア
- 痔処方薬
- 循環補助器具
- 脱毛治療
- 湿疹と乾癬
- 頭皮トリートメント
- 口唇ヘルペスの治療
- シラミ治療
- イボと疣贅の治療
- 髪と美容のサプリメント
- 見通し、予測、機会
イタリア
- 概要
- 流通
- 規制と分類
- 抗真菌薬
- 創傷治癒薬
- 防腐剤および消毒剤
- かゆみ止め
- ニキビ治療薬
- フェミニンインティメートケア
- リップケア
- 痔処方薬
- 循環補助器具
- 脱毛治療
- 湿疹と乾癬
- 頭皮トリートメント
- 口唇ヘルペスの治療
- シラミ治療
- イボと疣贅の治療
- 髪と美容のサプリメント
- 見通し、予測、機会
日本
- 概要
- 流通
- 規制と分類
- 抗真菌薬
- 防腐剤および消毒剤
- かゆみ止め
- ニキビ治療薬
- リップケア
- 痔処方薬
- 脱毛治療
- 湿疹と乾癬
- 頭皮トリートメント
- イボと疣贅の治療
- 髪と美容のサプリメント
- 見通し、予測、機会
英国
- 概要
- 流通
- 規制と分類
- 抗真菌薬
- 創傷治癒薬
- 防腐剤および消毒剤
- かゆみ止め
- ニキビ治療薬
- フェミニンインティメートケア
- リップケア
- 痔処方薬
- 脱毛治療
- 湿疹と乾癬
- 頭皮トリートメント
- 口唇ヘルペスの治療
- シラミ治療
- イボと疣贅の治療
- 髪と美容のサプリメント
- 見通し、予測、機会
米国
- 概要
- 流通
- 規制と分類
- 抗真菌薬
- 創傷治癒薬
- 防腐剤および消毒剤
- かゆみ止め
- ニキビ治療薬
- フェミニンインティメートケア
- リップケア
- 痔処方薬
- 脱毛治療
- 湿疹と乾癬
- 頭皮トリートメント
- 口唇ヘルペスの治療
- シラミ治療
- イボと疣贅の治療
- 髪と美容のサプリメント
- 見通し、予測、機会
厳選された市場概要
- オーストラリア
- カナダ
- インド
- メキシコ
- ポーランド
- 韓国
ブランドのケーススタディ
- CeraVe
- Cetaphil
- ChapStick
- Mighty Patch
見通し
- 世界の短期見通し
- 世界の長期見通し
- 主要市場の短期的見通し
- 主要市場の長期的見通し
There are countless opportunities for marketers to capitalise on the growth potential of skincare and aesthetic products, and the pandemic has shown that hygiene and personal care have become unprecedented concerns for consumers across the world.
With overall sales held back to a degree by the stabilisation of antiseptics & disinfectants following a pandemic-related spike, much of the Derma market is actually in rude health, featuring exciting pockets of dynamism and opportunities for future growth. Strong showings among lip care, acne remedies and wound healers are just a few signs of strong demand. The picture is even brighter online, with the e-commerce skincare market taking almost $3bn in sales and enjoying year-on-year strong growth.
Launch activity remains key to driving growth, with innovations in delivery format and formula frequent, while niches such as post-surgery recovery can potentially reach new audiences. A+P investment has proved an important growth driver in some areas - with marketers turning to digital channels to educate consumers and promote their products. Personalisation is also a key trend, with consumers looking for something more than a "one-size-fits-all" skincare solution.
By examining 8 core markets in detail (and additional key markets in brief), analysing brand performances and launch activity, our latest Dermatologicals report aims to investigate the untapped potential in this CHC category.
Key Features of the report:
- An in-depth exploration of the Dermatologicals market, including Antifungals, Wound healers, Acne remedies, Anti-itch & more, plus coverage of adjacencies such as Hair & beauty supplements
- Coverage of 8 major countries from across the globe, with topline sales, brand performances, new developments, launches and promotional campaigns, as well as additional key markets in brief
- Very latest mid-year 2023 sales from DB6 , our dedicated CHC sales database, plus historical growth rates to help track performance fluctuations
- Antifungals sales segmented into general, VYI and nail presentations
- Case studies of key Derma brands, highlighting success factors, sales, NPD and A+P activity, including digitally-native and online brands
- A look to the future includes long-term forecast sales for all categories and countries to 2027 & 2032, plus the most up-to-date short-term forecasts
Categories covered in this report include:
|
|
*sales tracked under VMS in DB6.
8 individual markets profiled in depth:
|
|
Plus selected additional markets in brief:
|
|
The report features the latest mid-2023 sales data from our dedicated DB6 database, including topline historical sales globally, by country and category, as well as individual brand performances, and long-term forecasts to 2027 and 2032.
Diving into the factors affecting the Dermatologicals market, from consumer trends and regulatory changes to A+P campaigns and new product launch activity, this report sheds light on trends & developments across 8 in-depth country profiles with insights and predictions, as well as shorter profiles of other key markets .
Key questions investigated in this report:
- What are the key differences from market to market in terms of growth trends, regulations and competitive landscape?
- Which marketers and brands stand out and why?
- How will NPD benefit Dermatologicals in the years ahead?
- What are the opportunities for e-commerce in the global skincare market?
- What new niches and demographics remain underserved?
- How can marketers best respond to the growing demand for "clean" and sustainable products?
Data analysis within each country profile sees Antifungals sales divided into VYI, nail and general presentations .
The important adjacent category of hair & beauty supplements is also investigated.
Assessing the short-term outlook, the report also includes full year 2023 & 2024 forecasts for all categories in each market profiled.
With a high degree of launch activity among Dermatologicals, new product development is explored across markets. Brand case studies evaluate the key lessons to be learned from rising star brands and established products, including consumer messaging, digital strategies, line extensions, portfolio development and brand strategies.
Table of Contents
Executive Summary
- Global overview
- Competitive landscape
- Innovation round-up
- Key trends by category
- Outlook, forecast & opportunities
Brazil
- Overview
- Distribution
- Regulations & Classifications
- Antifungals
- Wound healers
- Antiseptics & disinfectants
- Anti-itch
- Acne remedies
- Feminine intimate care
- Lip care
- Haemorrhoid preparations
- Circulatory aids
- Hair loss treatments
- Eczema & psoriasis
- Scalp treatments
- Lice treatments
- Hair & beauty supplement
- Outlook, forecast & opportunities
China
- Overview
- Distribution
- Regulations & Classifications
- Antifungals
- Wound healers
- Antiseptics & disinfectants
- Anti-itch
- Acne remedies
- Feminine intimate care
- Lip care
- Haemorrhoid preparations
- Hair loss treatments
- Scalp treatments
- Cold sore treatments
- Wart & verruca treatments
- Hair & beauty supplements
- Outlook, forecast & opportunities
France
- Overview
- Distribution
- Regulations & Classifications
- Antifungals
- Wound healers
- Antiseptics & disinfectants
- Anti-itch
- Acne remedies
- Feminine intimate care
- Lip care
- Haemorrhoid preparations
- Circulatory aids
- Hair loss treatments
- Eczema & psoriasis
- Scalp treatments
- Cold sore treatments
- Lice treatments
- Wart & verruca treatments
- Hair & beauty supplements
- Outlook, forecast & opportunities
Germany
- Overview
- Distribution
- Regulations & Classifications
- Antifungals
- Wound healers
- Antiseptics & disinfectants
- Anti-itch
- Acne remedies
- Feminine intimate care
- Lip care
- Haemorrhoid preparations
- Circulatory aids
- Hair loss treatments
- Eczema & psoriasis
- Scalp treatments
- Cold sore treatments
- Lice treatments
- Wart & verruca treatments
- Hair & beauty supplements
- Outlook, forecast & opportunities
Italy
- Overview
- Distribution
- Regulations & Classifications
- Antifungals
- Wound healers
- Antiseptics & disinfectants
- Anti-itch
- Acne remedies
- Feminine intimate care
- Lip care
- Haemorrhoid preparations
- Circulatory aids
- Hair loss treatments
- Eczema & psoriasis
- Scalp treatments
- Cold sore treatments
- Lice treatments
- Wart & verruca treatments
- Hair & beauty supplements
- Outlook, forecast & opportunities
Japan
- Overview
- Distribution
- Regulations & Classifications
- Antifungals
- Antiseptics & disinfectants
- Anti-itch
- Acne remedies
- Lip care
- Haemorrhoid preparations
- Hair loss treatments
- Eczema & psoriasis
- Scalp treatments
- Wart & verruca treatments
- Hair & beauty supplements
- Outlook, forecast & opportunities
UK
- Overview
- Distribution
- Regulations & Classifications
- Antifungals
- Wound healers
- Antiseptics & disinfectants
- Anti-itch
- Acne remedies
- Feminine intimate care
- Lip care
- Haemorrhoid preparations
- Hair loss treatments
- Eczema & psoriasis
- Scalp treatments
- Cold sore treatments
- Lice treatments
- Wart & verruca treatments
- Hair & beauty supplements
- Outlook, forecast & opportunities
USA
- Overview
- Distribution
- Regulations & Classifications
- Antifungals
- Wound healers
- Antiseptics & disinfectants
- Anti-itch
- Acne remedies
- Feminine intimate care
- Lip care
- Haemorrhoid preparations
- Hair loss treatments
- Eczema & psoriasis
- Scalp treatments
- Cold sore treatments
- Lice treatments
- Wart & verruca treatments
- Hair & beauty supplements
- Outlook, forecast & opportunities
Selected Markets in Brief
- Australia
- Canada
- India
- Mexico
- Poland
- S Korea
Brand Case Studies
- CeraVe
- Cetaphil
- ChapStick
- Mighty Patch
Outlook
- Global short-term outlook
- Global long-term outlook
- Short-term prospects for key markets
- Long-term prospects for key markets
